Cargando…
A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
Purpose: Our study is designed to develop and certify a promising prognostic signature for hepatocellular carcinoma (HCC). Materials and methods: We retrospectively analyzed mRNA expression profiles and clinicopathological data fetched from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus...
Autores principales: | Xie, Hui, Liu, Shouping, Zhang, Ziying, Chen, Peng, Tao, Yongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477431/ https://www.ncbi.nlm.nih.gov/pubmed/32913470 http://dx.doi.org/10.7150/jca.44573 |
Ejemplares similares
-
GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Zhang, Wen, et al.
Publicado: (2021) -
Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016) -
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
por: Wei, Yongguang, et al.
Publicado: (2023) -
Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017) -
Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)